Edition:
United States

Cardiome Pharma Corp (CRME.OQ)

CRME.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
3:59pm EST
Change (% chg)

$-0.07 (-4.43%)
Prev Close
$1.58
Open
$1.65
Day's High
$1.65
Day's Low
$1.48
Volume
28,092
Avg. Vol
29,161
52-wk High
$4.83
52-wk Low
$1.29

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 11 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 4 5 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 4 8.23 8.70 7.61 10.00
Quarter Ending Mar-18 2 7.80 8.40 7.20 --
Year Ending Dec-17 5 25.07 25.70 24.50 31.88
Year Ending Dec-18 5 40.10 47.62 35.56 46.77
Earnings (per share)
Quarter Ending Dec-17 4 -0.18 -0.17 -0.20 -0.09
Quarter Ending Mar-18 2 -0.19 -0.17 -0.22 --
Year Ending Dec-17 6 -0.74 -0.30 -0.88 -0.35
Year Ending Dec-18 5 -0.50 0.10 -0.81 -0.22

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 7.42 6.02 1.40 18.83
Quarter Ending Jun-17 6.96 5.75 1.20 17.30
Quarter Ending Mar-17 6.92 5.20 1.72 24.91
Quarter Ending Dec-16 6.58 7.02 0.44 6.72
Quarter Ending Sep-16 5.73 5.19 0.54 9.43
Earnings (per share)
Quarter Ending Sep-17 -0.18 -0.20 0.02 -13.64
Quarter Ending Jun-17 -0.17 -0.26 0.09 -52.94
Quarter Ending Mar-17 -0.16 -0.20 0.04 -26.58
Quarter Ending Dec-16 -0.16 -0.17 0.01 -7.39
Quarter Ending Sep-16 -0.20 -0.16 0.04 -20.79

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 8.23 8.23 9.41 9.41 10.00
Quarter Ending Mar-18 7.80 7.80 9.05 9.05 --
Year Ending Dec-17 25.07 25.07 28.54 28.54 31.88
Year Ending Dec-18 40.10 40.10 44.83 44.83 46.77
Earnings (per share)
Quarter Ending Dec-17 -0.18 -0.18 -0.16 -0.16 -0.09
Quarter Ending Mar-18 -0.19 -0.19 -0.16 -0.16 --
Year Ending Dec-17 -0.74 -0.82 -0.69 -0.69 -0.35
Year Ending Dec-18 -0.50 -0.50 -0.42 -0.42 -0.22

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 3
Quarter Ending Mar-18 0 0 0 2
Year Ending Dec-17 0 0 0 5
Year Ending Dec-18 0 0 0 4
Earnings
Quarter Ending Dec-17 0 0 0 4
Quarter Ending Mar-18 0 0 0 2
Year Ending Dec-17 0 0 1 5
Year Ending Dec-18 0 0 0 4